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Summary of Recommendations 1. In adult and adolescent patients ( Ն 14 years of age) complaining of chronic cough, we recommend that validated and reliable health-related quality of life (QoL) questionnaires be used as the measurement of choice to assess the impact of cough on patients (Grade 1B) .
2. In adults and adolescents with chronic cough, we recommend the Cough-Specifi c Quality-of-Life Questionnaire and Leicester Cough Questionnaire, as they are the most extensively studied and commonly used previously validated and reliable coughspecifi c health-related QoL questionnaires to assess the impact of cough (Grade 1B) .
3. In children ( , 14 years of age) with chronic cough, we recommend that validated and reliable healthrelated QoL questionnaires be used as the measurement of choice to assess the impact of cough (Grade 1B) . 4 . In children ( , 14 years of age) with chronic cough, we recommend the Parent Cough-Specifi c Quality of Life Questionnaire, the most extensively studied and commonly used previously validated and reliable health-related QoL questionnaire, as the measurement of choice to assess the impact of cough (Grade 1B) .
5.
To standardize the development, utilization, and reporting of cough-specifi c QoL questionnaires, we suggest that cough counting alone not be used to estab lish validity of the questionnaires (consensus based [CB] ) .
6.
To standardize the development, use, and reporting of cough severity by visual analog scales (VASs) or numeric rating scales, we suggest that they be used in standard fashion (CB) .
7.
To ensure the integrity of health-related QoL questionnaires and other patient-reported outcomes that have been shown to be valid and reliable, we suggest that a modifi ed version should not be used and reported unless the modifi ed version has been shown to be reliable and valid (CB) .
8. In adult and adolescent patients with cough of any duration, we suggest that tussigenic challenges have a role in research settings to understand mechanisms of cough (CB) . 9 . In patients of all ages, we recommend acoustic cough counting to assess cough frequency but not cough severity (Grade 1B) .
Cough, particularly chronic cough, is a common symptom. 1 Although the possible causes of this symptom are numerous, assessment of its etiologic factors should follow a systematic approach, as stated in previous guidelines. 2 -4 Furthermore, it is recognized that the assessment of antitussive medications should follow specifi c rules and use valid instruments. 5 Research out comes oft en measured in studies of cough include one or more of the following concepts: cough severity, cough impact on quality of life (QoL), cough frequency, or cough sensitivity. Most oft en, measures of frequency and severity of cough and cough impact on QoL have not been based on the use of standardized or valid measures. Therefore, more-precise assessments could help to determine the actual impact of cough on patients and allow for valid evaluation of outcomes, providing reliable measurement of the eff ect of antitussive therapies.
In this regard, the American College of Chest Physicians (CHEST) Expert Cough Panel initially reviewed the 2006 cough guidelines on this topic to develop the current updated recommendations and suggestions. 2 In the former guideline, recommendations stressed the need for optimally evaluating chronic cough and the effi cacy of cough-modifying agents by using both subject self-reporting and objective methods because they have the potential to measure diff erent aspects of 6 some health-related QoL instruments had been psychometrically tested but VASs had not; thus, the cough-specifi c health-related QoL instruments were recommended as the primary subjective outcome measure. Regarding objective methods, tussigenic challenges were recommended before and aft er interventions to assess the eff ect of therapy on cough sensitivity only in disease states in which cough refl ex sensitivity was known to be heightened. 6 Because a large number of studies and analyses have been published on cough assessment in the past decade, the CHEST Expert Cough Panel believed it necessary to review the current status of the previous recommendations and assess the need to develop new ones to advance the fi eld in this area. Th e purpose of the present committee was to evaluate instruments used by investigators in clinical research on chronic cough. Th e specifi c aims were to (1) assess the performance of tools designed to measure cough frequency, severity, and impact in adults, adolescents, and children with chronic cough and (2) make recommendations or suggestions related to these fi ndings.
Methods
Th e methodology used by the CHEST Guidelines Oversight Committee to select the Expert Cough Panel chair and the international panel of experts and to perform the synthesis of the evidence to develop the recommendations and suggestions has been previously published. 7 , 8 In addition to the quality of the evidence, the recommendation grading also includes a strength of recommendation dimension. In the context of practice recommendations, a strong recommendation applies to almost all patients, whereas a weak recommendation is conditional and only applies to some patients. In the context of research recommendations, such as the ones in this guideline, we intended for a strong recommendation (grade 1) to imply that we recommend using a particular cough assessment in almost all the cases and instances where such a tool is being considered. Th e strength of recommendation here is based on consideration of three factors: balance of benefi ts to harms, patient values and preferences, and resource considerations. Harms incorporate risks and burdens to the patient, which, for example, can include convenience or inconvenience, diffi culty of administration, and invasiveness. Th ese in turn aff ect patient preferences. Th e resource consider ations go beyond economics and should factor in time and other indirect costs. Th e authors of these recommendations have considered these parameters in determining the strength of the recommendations and associated grades.
Key questions and parameters of eligibility were developed for this topic. Existing guidelines, systematic reviews, and primary studies were assessed for relevance and quality and were used to support the evidence-based graded recommendations or suggestions. A highly structured consensusbased (CB) Delphi approach was used to provide expert advice on all guidance statements. Th e total number of eligible voters for each guidance statement varied based on the number of managed individuals recused from voting on any particular statements because of their potential confl icts of interest (COIs). For example, C. T. F., A. B. C., S. S. B., and R. S. I. were recused from developing and voting on the recommendations that included mentioning specifi c QoL instruments. Writing committee member COIs related to the recommendations were identifi ed and are presented in a COI grid (e-Appendix 1). Transparency of process was documented. Further details of the methods have been published elsewhere. 7 , 8 Th e Executive Committee of the CHEST Expert Cough Panel convened a subcommittee to formulate recommendations or suggestions that pertain to the assessment of cough frequency and severity. Th is subcommittee on assessment of cough based its recommendations on a recently published comparative eff ectiveness review (CER) commissioned by the US Agency for Healthcare Research and Quality (AHRQ) 9 and a corresponding summary. 5 Various members of the Expert Cough Panel provided the stimulus for the AHRQ CER (R. S. I.) and were invited to participate as key informants, technical expert panelists, and peer reviewers. 9 Th e CER included a comprehensive search of the literature indexed in MEDLINE, Embase, and the Cochrane Database of Systematic Reviews to identify English-language evaluative studies of instruments used to assess the frequency or impact of acute or chronic cough. Included studies had to (1) compare one cough assessment with another or with clinical assessment of cough or (2) evaluate change in response to treatment over time using a given tool. Th e literature search began with the inception of these databases; the last literature search date for the CER was June 4, 2012. Th e literature search was subsequently updated by two authors of the CER (R. R. C., D. C. M), who are also members of the subcommittee on assessment of cough, using the same selection criteria used for the original CER project. Th is updated literature search identifi ed 27 eligible studies 10 -36 published between June 2012 and November 2013, inclusive, that were not included in the CER.
Th e CER 9 included an analytic framework constructed by using the general approach of specifying the population of interest, interventions, comparators, outcomes, timing of outcomes, and settings (PICOTS) to address the following key question: In adults and adolescents ( Ն 14 years of age) and children ( , 14 years of age), what is the comparative diagnostic accuracy, therapeutic effi cacy, and patient outcome effi cacy of instruments used to assess cough? Th e criteria used to screen articles for inclusion and exclusion at both the title-and-abstract and the full-text screening stages are detailed in Table 1 . Figure 1 depicts this key question within the context of the PICOTS framework. Th e fi gure shows that the CER compared the diagnostic accuracy, therapeutic effi cacy, and patient outcome effi cacy of instruments to assess the severity, frequency, and impact of cough on patient outcomes. Subgroups considered included children aged , 14 years and patients with diff ering underlying cough etiologies. Th e subcommittee formulated the additional key clinical research questions presented in the Results section.
Th e strength of the evidence for the key question was rated using the general approach described in the Methods Guide for Eff ectiveness and Comparative Eff ectiveness Reviews 37 and the Methods Guide for Medical Test Reviews . 38 In brief, the approach required assessment of four domains: risk of bias, consistency, directness, and precision. Th ese domains were considered qualitatively, and a summary rating of high, moderate, or low strength of evidence was assigned aft er discussion by two reviewers (R. R. C. and D. C. M.) ( Table 2 ) . 14 , 16 , 19 -22 , 24 , 29 , 31 , 32 , 34 -36 , 39 -100 In some cases, high, moderate, or low ratings were impossible or imprudent to make. For example, when no evidence was available or when evidence on the outcome was too weak, sparse, or inconsistent to permit any conclusion to be drawn, a grade of insuffi cient was assigned. Two members of the subcommittee on assessment of cough revised the strength of evidence conclusions reported in the AHRQ report to include additional information reported in the studies identifi ed by the updated literature search. Prior to publication, experts reviewed this guideline and addressed all suggestions and criticisms. 
Results
Th e original CER report identifi ed 115 articles representing 121 unique studies that underwent full-text review and 78 studies that met inclusion criteria for the review. 5 , 9 Th e updated literature search identifi ed an additional 105 studies for full-text review, 27 of which met inclusion criteria, for a total of 105 eligible studies.
Th e updated search did not change the conclusions of the initial report. The ACOS has been revised and replaced by the CQLQ.
Patients ( Ն 14 Years of Age) Complaining of Chronic Cough?
Summary of the Evidence and Interpretation: A variety of tools are available to assess cough, capturing diff erent concepts used to evaluate various aspects of the symptom. 5 , 9 Th e choice of instruments in studies is determined by the specifi c research question and study design. Patientreported outcomes, such as QoL questionnaires and VASs, refl ect the patient's experience of the impact and severity of coughing, whereas cough counting provides objective quantifi cation of the symptom, and cough challenge testing off ers mechanistic insights. Cough frequency can be measured using electronic audio and video recording devices. Limited data suggest that audio recordings may be marginally more accurate than video recordings. 75 Although both are reliable compared with other methods of assessing cough frequency, the moderate to poor correlations between cough counting and QoL appear to demonstrate a lack of convergent validity between the two constructs being measured. 5 , 9 As such, all these tools complement one another and are frequently used in combination. Furthermore, although the majority of studies on cough assessment evaluated various aspects of the comparative diagnostic accuracy of the various cough measurement instruments, they did not evaluate their comparative therapeutic or patient outcome effi cacies. 5 , 9 Although multidimensional QoL questionnaires describe only one facet of cough consequences, they appear to be the most comprehensive instruments to evaluate the impact of this symptom on the patient. 9 QoL instruments may vary in content and therefore measure diff erent aspects of QoL so that some may be more useful in certain situations. Furthermore, because they provide a personal subjective evaluation of the eff ects of cough, which may diff er greatly from one patient to another, some assessments may be better for subgroups of patients. Because health-related QoL studies have tended to focus on populations with longer durations of cough, we have specifi ed chronic cough in the present recommendation. In this context, healthrelated QoL questionnaires have been shown to be valid and reliable in adults and adolescents and in pediatric populations. 5 , 9 In adults and adolescents, QoL questionnaires are based on self-report. In the pediatric population, the questionnaires are completed by the parents, not the child; therefore, the results refl ect the parents' perception of the impact of cough on their child's QoL. Older children (generally aged . 7 years) may be able to report their QoL, but self-reported pediatric coughspecifi c QoL questionnaires are not yet available. ( Table 2 ) . 5 , 9 Although there is good responsiveness data for the CQLQ and LCQ, they are limited at this time. 5 , 9 Th ese two questionnaires have been the most extensively studied, whereas other cough-specifi c as well as general and disease-focused (eg, cough in patients with lung cancer) health-related QoL instruments have not been extensively studied or used. 9 2. In adults and adolescents with chronic cough, we recommend the CQLQ and LCQ, as they are the most extensively studied and commonly used previously validated and reliable cough-specifi c health-related QoL questionnaires to assess the impact of cough (Grade 1B) .
Clinical Research Question 3: in Children ( , 14 Years of Age) With Chronic Cough, Which Is the Measure ment of Choice to Assess the Impact of Cough?
Summary of the Evidence and Interpretation: As for adults, QoL questionnaires have been demonstrated to be valid and reliable instruments to assess the impact of cough in children. 5 , 9 Because of limited and insuffi cient evidence to determine the reliability or concurrent validity of the various cough diaries, numeric rating scales, VASs, or tussigenic challenges, these are not recommended as primary outcome measures to assess the impact of cough. 5 , 9 Based on studies performed in children, it appears that electronic audio and video recording devices are valid methods of assessing cough frequency. 5 , 9 Because cough counting does not lend itself to directly measuring the impact of cough as perceived by the patient, establishing concurrent validity of cough counting may best be assessed by comparing one cough counting method with another cough frequency measure. Summary of the Evidence and Interpretation: In children, the Parent Cough-Specifi c Quality of Life Questionnaire (PC-QOL), the most extensively studied QoL instrument in this age-group, has been found to be a reliable and valid instrument of measuring parental perception of the impact of chronic cough on their child ( Table 2 ) . 5 , 9 Th is questionnaire has content validity based on its development with input from parents of children with chronic cough. 99 Although there is good responsiveness data for the PC-QOL, they are limited at this time ( Table 2 ) . 5 , 9 4. In children ( , 14 years of age) with chronic cough, we recommend the PC-QOL, the most extensively studied and commonly used previously validated and reliable health-related QoL questionnaire, as the measurement of choice to assess the impact of cough (Grade 1B) . Summary of the Evidence and Interpretation: Th e literature draws moderate to poor correlations between cough counting and health-related QoL, suggesting that these outcomes are measuring diff erent concepts related to the phenomenon of coughing. 5 , 9 Despite the fact that cough frequency monitoring appears to be measuring data refl ecting a concept diff erent from health-related QoL or cough severity, its measurement may still be informative based on study design and outcomes (eg, assessment of drug effi cacy).
In children (

Clinical Research Question 5: in Adult and
5.
To standardize the development, utilization, and reporting of cough-specifi c QoL questionnaires, we suggest that cough counting alone not be used to establish validity of the questionnaires (CB) .
Clinical Research Question 6: How Should VASs or Numeric Rating Scales Be Used to Assess Cough?
Summary of the Evidence and Interpretation: VASs and patient diaries are widely used in both clinical research and practice. Although they have the potential to assess cough severity, few data exist on their accuracy in doing so, and correlations with other cough measurement tools have been inconsistent. 5 , 9 Th e panel considered that if a VAS is used as an outcome measure, it must be done so in a standardized manner. 103 -106 For example, to establish concurrent validity for a cough-specifi c QoL scale, it is important to ensure that the phenomenon measured by the VAS is that of cough. Th erefore, it is important to use the word "cough" in the descriptor at both ends of the scale, and words such as "symptoms" should not be interchanged with the word "cough. " For the purpose of promoting reliability and validity in the use of the VAS, the ends of the scale should be closed by perpendicular lines, and the descriptions on each end should be outside these lines and not within the scale itself ( Fig 2 ) . 103 Th is design will help to avoid confusion on the part of the subject about where to mark the line.
6.
To standardize the development, use, and reporting of cough severity by VASs or numeric rating scales, we suggest that they be used in standard fashion (CB All translations of existing questionnaires into another language should be conducted using an established methodology to preserve content validity and other measurement properties (eg, backward and forward translation steps, cognitive interviews, international harmonization meetings). 108 Th e results of these procedures must be published. 5 , 9 suggesting that cough counting is not a reliable way to assess the impact of coughing on patients. If performed, however, it should be done through objective means. Although electronic audio and video recording devices are reliable compared with other methods of assessing cough frequency, 5 , 9 the moderate to poor correlations between cough counting and QoL appear to demonstrate a lack of convergent validity between the two constructs being measured.
9.
In patients of all ages, we recommend acoustic cough counting to assess cough frequency but not cough severity (Grade 1B) .
Areas for Future Research
To advance the fi eld, a number of research endeavors should be undertaken, as follows:
• It should not be assumed that QoL questionnaires would perform equally in all studies, across diff erent cultures, and in diff erent populations. Th erefore, to assess the performance of QoL questionnaires, their reliability and validity should be reassessed in all studies going forward, including longitudinal studies. Concurrent validity of QoL questionnaires may be assessed by comparing results of cough severity with QoL or QoL of one questionnaire with another . 28 , 109 • To standardize the development, use, and reporting of responsiveness of health-related QoL questionnaires, the minimal important diff erence should be assessed with a prospective (eg, Punum Ladder) 41 as well as a retrospective (eg, global rating of change scale) measure of change to assess whether a consistent diff erence exists between the two. Based on an empirically supported theory by Streiner and Norman, 110 there is recall bias inherent in retrospective measures. 41 Th e only study comparing the two types of measures to calculate the minimal important diff erence found a diff erence when prospective and retrospective measures of change were used . 41 If future studies confi rm this fi nding and reveal that the diff erence is consistent, a recommendation should be made about which type of change measure should be routinely used.
• Because there are limited data on the responsiveness of electronic audio and video cough counting devices, 5 , 9 future research should focus on this gap in knowledge as well as on determining the most useful duration of the monitoring session.
• Th ere is a need to establish reliability and validity of cough-specifi c VASs and numeric rating scales using appropriate methodology. 5 , 9 • Th ere is a need to develop self-reported pediatric cough-specifi c QoL questionnaires for older children.
• When changing an established questionnaire from a hard copy to an electronic format, measurement properties must be confi rmed because the change represents instrument modifi cation. 109 • Although QoL questionnaires provide important infor mation in the research setting, future research should be directed to transitioning the use of these questionnaires in an appropriate format for the clinical setting. 111 
Conclusions
Since publication of the 2006 CHEST cough guidelines, it is clear that the fi eld of cough assessment has advanced based on the results of the systematic review commissioned by AHRQ and performed by methodologists with no confl icts of interest at the Duke Evidence-based Practice Center. By updating the original review through November 2013 and using the updated results as the basis for the present deliberations, the CHEST Expert Cough Panel has made a series of recommendations and suggestions for carrying out clinical research in assessing cough. This article has also identified gaps in our knowledge and areas for future research.
